Background illustration for clinical trials search

Paid Clinical Trials Bradenton

Discover 1,438 paid clinical trials in Bradenton, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas

for
Intracranial Meningioma, Recurrent Meningioma,
Location: Tampa FL, Boca Raton FL, Deerfield Beach FL,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT02523014

Phase2, Recruiting

Anticoagulation in ICH Survivors for Stroke Prevention and Recovery

for
Intracerebral Hemorrhage, Atrial Fibrillation
Location: Tampa FL, Clearwater FL, Port Saint Lucie FL,
Sponsor: Yale University

Sex: All

Age: 18+

Code: NCT03907046

Phase3, Recruiting

Trifecta-Kidney cfDNA-MMDx Study

for
Kidney Transplant Rejection
Location: Tampa FL, Richmond VA, Baltimore MD, St Louis MO,
Sponsor: University of Alberta

Sex: All

Age: 0+

Code: NCT04239703

Recruiting

Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer

for
Hematopoietic and Lymphatic System Neoplasm,
Location: Tampa FL, Fort Myers FL, Orlando FL, Gainesville FL,
Sponsor: Children's Oncology Group

Sex: Female

Age: 0 - 39

Code: NCT06513962

Phase3, Recruiting

Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors

for
Metastatic Malignant Neoplasm in the Liver,
Location: Tampa FL, Fort Myers FL, Bonita Springs FL,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT05040360

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators

for
Cystic Fibrosis
Location: Tampa FL, Orlando FL, Gainesville FL, Miami FL,
Sponsor: Nicole Hamblett

Sex: All

Age: 12+

Code: NCT06504589

Recruiting
New

Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)

for
Ulcerative Colitis, Inflammatory Bowel Diseases,
Location: Tampa FL, Miami FL, Roswell GA, Cleveland OH
Sponsor: Athos Therapeutics Inc

Sex: All

Age: 18 - 70+

Code: NCT07513181

Phase2, Recruiting

A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

for
Crohn Disease
Location: Tampa FL, Naples FL, Miami FL, Jacksonville FL,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07499232

Phase3, Recruiting

A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

for
Ulcerative Colitis, Ulcerative Colitis Chronic
Location: Tampa FL, Orlando FL, Miami FL, Chapel Hill NC,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18 - 70+

Code: NCT06598943

Phase2, Recruiting

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

for
High-Risk Non-Muscle-Invasive Bladder Cancer
Location: Largo FL, Oxford FL, Gainesville FL, Jacksonville FL,
Sponsor: CG Oncology, Inc.

Sex: All

Age: 18+

Code: NCT06567743

Phase2, Recruiting

A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer

for
Non-Muscle Invasive Bladder Neoplasms
Location: Largo FL, Atlanta GA, Myrtle Beach SC, Lafayette LA,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06919965

Phase3, Recruiting

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

for
Metastatic Castration Sensitive Prostate Cancer (mCSPC),
Location: Largo FL, Myrtle Beach SC, Dalton GA, Ringgold GA,
Sponsor: Pfizer

Sex: Male

Age: 18+

Code: NCT07028853

Phase3, Recruiting

Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T

for
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Location: Largo FL, Riverview FL, Ocala FL, Daytona Beach FL,
Sponsor: Dendreon

Sex: Male

Age: 18+

Code: NCT06134232

Phase2, Recruiting

Longitudinal Measurements of Flow in Cerebrospinal Fluid Shunts With a Wireless Thermal Anisotropy Measurement Device

for
Hydrocephalus
Location: Tampa FL, Chicago IL, Rolling Meadows IL
Sponsor: Rhaeos, Inc.

Sex: All

Age: 5 - 70+

Code: NCT06086561

Recruiting

ARVIS TKA vs Conventional TKA

for
Osteoarthritis
Location: Tampa FL
Sponsor: Foundation for Orthopaedic Research and Education

Sex: All

Age: 18+

Code: NCT06663384

Recruiting

Deep Vein Thrombosis Prophylaxis Adherence: Enoxaparin vs Rivaroxaban

for
Deep Vein Thrombosis, Venous Thromboembolism
Location: Tampa FL
Sponsor: Florida Orthopaedic Institute

Sex: All

Age: 18+

Code: NCT04169269

Recruiting

Safety and Effectiveness of the HIT Reverse HRS

for
Degenerative Joint Disease, Osteoarthritis, Hip,
Location: Tampa FL, Miami FL, New Albany OH, Somers Point NJ
Sponsor: Hip Innovation Technology

Sex: All

Age: 50 - 70+

Code: NCT05357378

Recruiting

Study of ALTO-101 in Patients With Schizophrenia

for
Schizophrenia, Cognitive Impairment
Location: Tampa FL, Hollywood FL, Snellville GA, Gaithersburg MD,
Sponsor: Alto Neuroscience

Sex: All

Age: 21 - 55

Code: NCT06502964

Phase2, Recruiting
New

A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)

for
Renal Insufficiency, Chronic
Location: Riverview FL, Savannah GA, Charlotte NC, Louisville KY,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT07624305

Phase3, Recruiting
New

A Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's Disease

for
Sjögren's Disease
Location: Tampa FL, Bellaire TX, Oklahoma City OK, Sherbrooke
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07737743

Phase2, Recruiting